Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Aug 19, 2019
Solid fundamentals helping propel Thermo Fisher Scientific higher

Solid fundamentals helping propel Thermo Fisher Scientific higher

Medical equipment provider Thermo Fisher Scientific (NYSE: TMO) has been trending higher for over two and a half years. Sure the stock pulled back in the fourth quarter of 2018, but even then it held up better than most stocks. One of the biggest reasons behind the rally has been good, consistent fundamentals.

Over the last three years the company has been able to grow earnings at a rate of 15% per year while sales have grown at a rate of 14% per year. In the most recent quarterly report, earnings increased by 11% while sales increased by 4%. Analysts expect the company to see earnings increase by 10% for 2019 as a whole while sales are expected to increase by 4.4%.

The company’s management efficiency measurements are above average as well with a return on equity of 17% and a profit margin of 21%.

The Tickeron Fundamental Analysis Overview shows a profit vs. risk rating of 9 for Thermo Fisher, indicating low risk on high returns. The average profit vs. risk rating for the industry is 75, placing this stock better than average.

The Tickeron Valuation Rating of 11 indicates that the company is seriously undervalued in the industry. A rating of 1 points to the most undervalued stocks, while a rating of 100 points to the most overvalued stocks. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization.

The daily chart shows that the stock has been trending higher since the end of December and there is a trend line connecting the lows from the last five months. The slope of the trend isn’t that high, but that seems to go along with the consistency of the fundamentals. The stock hasn’t rocketed higher and then fallen back, it has been on a consistent climb higher.

We see that the stock just recently hit the trend line again and that is the second time it has done so in August. The overbought/oversold indicators dropped in to oversold territory early in August and then reversed, but pulled back down again this past week. The daily stochastic readings made a bullish crossover on August 16 and that could be a good sign for the stock.

The stock also broke below its lower Bollinger band in early August and according to the Tickeron Technical Analysis Overview, in 22 of 31 cases where TMO's price broke its lower Bollinger Band, its price rose further in the following month. That puts the odds of a rally at 71% based on the past statistics.

Taking a look at the weekly chart we see that Thermo Fisher closed below its 52-week moving average for one week back in December and that is the only time the stock has done that in the last two and a half years.

The weekly stochastic readings have recently dipped below the 50 level for the first time since December and for only the seventh time in the last two and a half years. Almost all of the previous instances have marked good buying points for investors.

The sentiment toward Thermo Fisher is relatively bullish, but it seems to be warranted based on how well the company and stock have performed in recent years. There are 17 analysts following the stock at this time and 14 have it rated as a “buy”. There are also two “hold” ratings and one “sell” rating. This puts the overall buy percentage at 82.4% and that is above average.

The short interest ratio is at 1.9 currently and that is below average. This means that both analysts and short sellers are slightly more bullish toward Thermo Fisher than the average stock, but with the fundamental and technical picture, the bullish sentiment seems to be appropriate.

Related Ticker: TMO

TMO's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for TMO turned positive on May 22, 2026. Looking at past instances where TMO's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 28, 2026. You may want to consider a long position or call options on TMO as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMO advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TMO moved out of overbought territory on June 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where TMO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

TMO moved below its 50-day moving average on June 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TMO crossed bearishly below the 50-day moving average on April 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TMO broke above its upper Bollinger Band on May 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TMO entered a downward trend on May 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.383) is normal, around the industry mean (12.045). P/E Ratio (25.992) is within average values for comparable stocks, (140.083). Projected Growth (PEG Ratio) (1.554) is also within normal values, averaging (1.513). Dividend Yield (0.004) settles around the average of (0.008) among similar stocks. P/S Ratio (3.939) is also within normal values, averaging (7.067).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TMO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 15B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -3%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was -7%. MYGN experienced the highest price growth at 15%, while NOTV experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 1,265%. For the same stocks of the Industry, the average monthly volume growth was 1,464% and the average quarterly volume growth was 2,405%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 65
Price Growth Rating: 50
SMR Rating: 81
Profit Risk Rating: 93
Seasonality Score: 42 (-100 ... +100)
View a ticker or compare two or three
TMO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of analytical and environment monitoring instruments

Industry MedicalSpecialties

Profile
Details
Industry
Medical Specialties
Address
168 Third Avenue
Phone
+1 781 622-1000
Employees
122000
Web
https://www.thermofisher.com
Interact to see
Advertisement
Oracle Corporation (ORCL) has shown resilience in a volatile tech sector, maintaining a market capitalization around $590 billion amid broader market fluctuations. The stock trades within its 52-week range, reflecting investor responses to cloud computing demand and competitive pressures. Recent trading sessions have seen downward momentum, influenced by sector-wide reevaluations of AI investments and macroeconomic uncertainties. Despite this, ORCL's forward price-to-earnings ratio and dividend yield position it as a stable player in enterprise software, with focus on its multicloud strategy and partnerships driving long-term value in the latest market cycle.
NuScale Power (SMR) has experienced notable volatility in recent trading sessions, reflecting broader trends in the nuclear energy sector. The stock has traded within a wide range over the latest market cycle, influenced by shifts in investor sentiment toward small modular reactors amid rising energy needs from data centers and AI applications. While the company maintains a market capitalization in the mid-single-digit billions, its price action has been marked by pullbacks from earlier peaks, with momentum indicators suggesting potential stabilization. Broader industry factors, including regulatory support and partnerships, continue to underpin interest, though operational challenges persist. This positions SMR as a high-beta play in the clean energy space, appealing to growth-oriented investors monitoring sector developments.
Monolithic Power Systems (MPWR) has demonstrated robust performance in recent trading sessions, buoyed by its position in the semiconductor industry amid rising demand for power management solutions in AI and data centers. The stock has maintained upward momentum over the latest market cycle, reflecting broader sector trends where technology firms benefit from enterprise investments. With a market capitalization in the mid-$40 billion range and a forward price-to-earnings ratio indicating growth expectations, MPWR continues to attract investor interest. Recent weeks have seen the shares navigate volatility tied to macroeconomic factors, yet overall sentiment remains positive as the company leverages its fabless model to capitalize on efficiency-driven innovations in computing and automotive applications.
Quanta Services (PWR), a leader in infrastructure solutions for electric power, renewables, and communications, has demonstrated resilient performance in recent trading sessions. The stock has maintained upward momentum amid broader market cycles favoring energy and infrastructure sectors, driven by increasing demand for grid modernization and sustainable projects. Trading near its 52-week highs, PWR reflects positive investor sentiment, with a market capitalization exceeding $68 billion and a trailing P/E ratio around 68. Volatility has been moderate, influenced by sector-wide catalysts, positioning the company as a growth-oriented pick in the industrial space. This stock analysis highlights PWR's ability to capitalize on long-term trends in energy transition.
Teradyne (TER), a leader in automated test equipment and industrial robotics, has demonstrated resilient performance amid a favorable semiconductor market cycle. In recent weeks, the stock has maintained upward traction, outperforming broader indices like the Nasdaq, supported by AI-driven demand for chip testing solutions.
Curtiss-Wright Corporation (CW) has demonstrated resilience in recent trading sessions, navigating a period of moderate volatility within the aerospace and defense sector. The stock has shown upward momentum over the latest market cycle, supported by strong demand in commercial and military applications.
CrowdStrike Holdings (CRWD) has shown resilience in the cybersecurity sector amid broader market cycles, with shares experiencing moderate pullbacks in recent weeks following strong year-to-date gains. The stock trades near its upper range, reflecting investor optimism in AI-driven security innovations and platform adoption.
Arista Networks (ANET) has demonstrated resilience in recent trading sessions amid fluctuating tech market conditions. The stock has navigated broader sector headwinds, including competition in cloud networking and varying demand from hyperscale clients.
Galaxy Digital Holdings Ltd. (GLXY), a leading player in digital assets and blockchain investment, has shown resilience in recent trading sessions amid cryptocurrency market dynamics. The stock has navigated volatility driven by Bitcoin's price fluctuations, reflecting broader sector sentiment.
In the ever-shifting healthcare sector, CVS Health (CVS) and UnitedHealth Group (UNH) represent two powerhouse approaches: CVS as a retail pharmacy giant with integrated insurance and services, and UNH as a leading health insurer with diversified operations.
In the competitive retail landscape, American Eagle Outfitters (NYSE: AEO) is showing signs of robust upward potential as it navigates a strong 2025 performance.
In the dynamic world of satellite communications and broadband services, EchoStar Corporation (NASDAQ: SATS) has captured investor attention with a notable technical breakthrough. On December 8, 2025, the stock's 10-day moving average crossed above its 50-day moving average, signaling the onset of a bullish upward trend.
In an era where global investors demand instant access to markets, major players in the financial world are racing to extend trading hours beyond the traditional 9:30 a.m. to 4 p.m. ET window. This push is driven by surging foreign holdings of U.S. equities, which hit $17 trillion last year, and the growing appetite for nonstop trading in a 24/7 digital economy.
In the resilient gold mining sector, IAMGOLD Corporation (NYSE: IAG) has demonstrated an extraordinary uptrend throughout 2025, capitalizing on rising gold prices and operational milestones.
Within the rapidly evolving automotive retail landscape, Carvana Co. (NYSE: CVNA) has emerged as one of 2025’s standout performers. Once viewed as a highly volatile name, the company has transformed into a market leader as demand for online vehicle purchasing accelerates
Microsoft (MSFT) emerges as the AI-favored stock in 2025, outperforming Apple (AAPL) with a 16% year-to-date gain, compared to Apple’s 10% rise. The advantage stems from Microsoft’s deeper enterprise AI integration, accelerating cloud growth, and scalable software ecosystem.
ExxonMobil (XOM) emerges as the AI-preferred energy stock in 2025, posting a 10% year-to-date gain compared with Chevron’s (CVX) 2% increase. Stronger upstream production, exposure to high-growth assets, and expanding low-carbon initiatives support XOM’s momentum. Tickeron’s AI models signal continued upside for XOM, while CVX shows signs of overbought conditions and elevated downside risk.
Tesla (TSLA) emerges as the AI-preferred EV stock in 2025, posting a 19% year-to-date gain, while BYD (BYDDY) has declined 82%, reflecting diverging momentum across the global EV market. Tickeron’s AI trading bots indicate strong bullish conditions for TSLA, supported by positive momentum signals, whereas BYDDY shows sustained bearish trends.
Broadcom (AVGO) emerges as the AI-preferred semiconductor stock in 2025, posting a 48% year-to-date gain, compared with 37% for NVIDIA (NVDA), supported by stronger diversification across networking, infrastructure, and custom AI chips.